Vol. 3, Issue 4, Part E (2019)

Background: The purpose of this study was to evaluate briefly the spectrum of diseases affecting the spleen warranting its removal.

Methods: This was a retrospective study performed in JSS hospital of 34 patients who had undergone splenectomy between 2016 to 2018.

Results: Out of the patients operated, 5 (14.7%) were for blood dyscrasias with hypersplenism, 1 (2.9%) for splenic abscess and the rest was splenic injury. Ten patients had a platelet count less than 40 × 109/l during bleeding complications during or after surgery were rare (3%). Accessory spleens were removed in 2 patients. Convalescence was rapid and the mean hospital stay was 2.3 days (range 1–7 days). The patients were followed for a mean of 16 months (range 1–36 months) and resulting mortality was 3 out of 34 (8.9%).

Conclusion: Splenectomy should be undertaken only after careful balancing of the short and long term risks and potential benefits to the patient.